Elos Medtech Interim Report January 1 - March 31, 2019
Continued healthy growth and improved operating margin • Net sales for the quarter increased and amounted to SEK 189.9 (155.7) million, which corresponds to organic growth of 22.0%. After currency adjustments, our growth rate was 15.2%. During the quarter, a finished goods warehouse of SEK 13.3 million was sold to Bruel & Kjaer.• Excluding sales of finished goods, organic growth was 13.4% and adjusted for currency effects 6.8%.• Operating profit amounted to SEK 21.4 (10.9) million. Operating margin in the first quarter of 2019 was 11.3%, compared to 7.0% in the first quarter of 2018.